Pan-RAS IMM-1-104 activity in humanized 3D tumor models is independent of specific amino acid substitution

Title: Pan-RAS IMM-1-104 activity in humanized 3D tumor models is independent of specific amino acid substitution

Virtual poster presented at AACR Special Conference Targeting RAS March 7, 2023
Presenter: Sarah Kolitz, Ph.D., Immuneering Vice President, Translational Medicine
Abstract #: B201

 

Immuneering Corporation
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.